Vedere Bio II

Graphic of a graveyard with an orange sky and bats flying above

Biotech

The 2023 Biotech Graveyard

Nearly four times as many companies entered the biotech graveyard in 2023 compared to 2022.

Max Bayer , Gabrielle Masson Oct 31, 2023 6:00am

Closed sign in the window of a bar

Vedere Bio II, unimpressed by preclinical work, shuts down

Apr 3, 2023 10:35am